The page of NECLIFE. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 25-11-2024 is predicted based on technical analysis and should only be used as reference for learning purpose only.
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Morepen Lab | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Marksans Pharma | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kopran | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sequent Scienti | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
| Company | LTP | Change | Gain |
|---|---|---|---|
| State-Bank-of-India | 816.05 | 35.3 | 4.52 % |
| Tata-Consultancy-Services-Limited | 4244.6001 | 171.75 | 4.22 % |
| Company | LTP | Change | Loss |
|---|---|---|---|
| HDFC-Bank | 1745.6 | 4.4 | 0.25 % |
| Axis-Bank-Limited | 1142.4 | 3.25 | 0.29 % |
